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Spl574 MLV (murine leukemia virus) is a variant of Moloney ecotropic MLV (MoMLV) that is cytopathic
in Mus dunni cells and restricted by other mouse cells. Its host range and cytopathicity are due to a
mutation, S82F, at a site critical for binding to the CAT-1 receptor. To identify residues that affect
afﬁnity for receptor variants, virus with S82F was passed in restrictive cells. The env genes of the
adapted viruses contained 18 novel mutations, including one, E114G, present in 6 of 30 sequenced envs.
MoMLV-E114G efﬁciently infected all mouse cells as well as ecotropic MLV resistant Chinese hamster
cells. Virus with E114G and S82F induced large multinucleated syncytia in NIH 3T3 and SC-1 cells as
well asM. dunni cells. Inoculation of Mo-S82F,E114G into mice produced lymphomas typical of MoMLV.
Residues at env position 114 are thus important determinants of host range, and E114G suppresses host
range restriction due to S82F, but does not affect S82F-governed cytopathicity.
Published by Elsevier Inc.Introduction
Retrovirus receptors mediate virus binding and entry into host
cells. Sequence variations in receptor as well as virus envelope
glycoproteins can alter this interaction and can be responsible for
host range variations and for cytopathicity. The ecotropic mouse
leukemia viruses (E-MLVs) are rarely cytopathic although there are a
few known exceptions. In previous studies we identiﬁed two
unusual E-MLV variants that are cytopathic and also have altered
host range. Spl574 is a derivative of Moloney murine leukemia virus
(MoMLV) and efﬁciently infects cells of the Asian mouse, M. dunni,
but inefﬁciently infects cells of laboratory mice (Jung and Kozak,
2003). The second cytopathic virus, F-S MLV, is a variant of Friend
ecotropic MLV (FrMLV) and, unlike most other ecotropic viruses, is
capable of infecting Chinese hamster cells (Jung et al., 2004). Spl574
and F-S MLV both induce large multinucleated syncytia in M. dunni
cells. A third cytopathic virus, TR1.3, is a neuropathic FrMLV that
induces syncytia in SC-1 cells (Park et al., 1994).
The altered host range and cytopathicity of Spl574 and F-S MLV
have been attributed to a single amino acid change at the same site:
S82F in Spl574 and S84A in F-S MLV (Jung and Kozak, 2003; JungInc.
, Room 329, 4 Center Drive
301 480 6477.
rrarone),
il.com (R. Li),et al., 2004). The cytopathicity of TR1.3 is due to a single replacement
mutation, W102G (Park et al., 1994). These two sites together with
D84 in MoMLV (D86 in FrMLV) represent the critical amino acids
involved in interactions with the E-MLV CAT-1 receptor (Davey et al.,
1999; MacKrell et al., 1996). The virus binding domain of theM. dunni
CAT-1 receptor, dCAT-1, differs from that of the laboratory mouse
receptor, mCAT-1 (Eiden et al., 1993), and syncytium induction by
these viruses was linked to this sequence polymorphism. Virus
induced syncytia in stable transfected cells of other species expressing
dCAT-1 but not mCAT-1, although the transfected cells did not differ
in susceptibility to virus infection (Yan et al., 2008).
In this study we further examined the connection between
cytopathicity and host range and sought to identify Env residues
that serve to discriminate the rodent CAT-1 receptor variants. We
identiﬁed a second site mutation in viruses with S82F that
enhances E-MLV infectivity in some rodent cells and produces a
virus that is cytopathic in laboratory mouse cells. This substitu-
tion, E114G, alters a site that has previously been implicated in
FrMLV entry and in vivo pathogenesis (Masuda et al., 1996a;
Masuda et al., 1993).Results
Isolation of host range variants
Spl574 efﬁciently infects M. dunni cells where it induces
cytopathic foci of multinucleated cells, but less efﬁciently infects
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assay (Table 1). MoMLV carrying the SUenv substitution, S82F,
(Mo-S82F) shows the same host range as Spl574 (Table 1) and is
also cytopathic in M. dunni cells.
Spl574 and Mo-S82F were used to infect restrictive SC-1 or
NIH 3T3 cells; infection was done at an MOI of 0.1–1.0 based on
XC plaque-forming units on M. dunni cells. Culture ﬂuids were
collected when the cultures reached conﬂuency and were used to
infect fresh cells. After 1–2 reinfections, ﬂuids were tested for
infectious ecotropic virus on NIH 3T3 cells by the XC test and for
cytopathicity onM. dunni cells. Collected virus retained the ability
to induce syncytia on M. dunni cells, but showed a change in host
range; virus titers were nearly equivalent on M. dunni, SC-1 and
NIH 3T3 (Table 1).
Sequence analysis and mutagenesis
Viral env gene segments were ampliﬁed from SC-1 and NIH
3T3 cells infected with 4 independent stocks of adapted viruses
and 30 were sequenced (Table 2). 18 nonsynonymous mutations
were identiﬁed in 26 envs, 16 of which were found in single envs.
The most common mutation among the 9 envs from Mo-S82F
infected cells was reversion of S82F (5 envs), a change associated
with expanded MoMLV host range (Jung and Kozak, 2003). Of the
21 envs from Spl574 infected cells, 12 carried reversions of S82F.
8 of these envs retained S82F, 6 of which also carried E114G,Table 1
Virus titers of MoMLV variants on rodent cells.
Virus Virus grown in Log10 virus titer
a
M. dunni NIH 3T3 SC-1 E36 Rat2
Mo-MLV NIH 3T3 2.6 7.3 6.3 o0 4.8
Spl574 M. dunni 4.7 2.7 2.0 o0 ND
NIH 3T3 5.0 5.4 4.8 ND ND
SC-1 4.5 5.4 4.3 ND ND
Mo-S82F M. dunni 5.0 2.2 2.0 ND ND
NIH 3T3 4.8 5.6 5.7 ND ND
SC-1 4.8 5.2 4.8 ND ND
Mo-E114G NIH 3T3 5.6 6.9 6.6 1.7 5.5
Mo-S82F,E114G NIH 3T3 5.5 5.1 4.3 2.9 o0
a Virus titers were determined by the XC overlay test (Rowe et al., 1970).
Titers represent the number of XC PFU in 0.2 ml and are averages of at least
3 experiments. ND, not done.
Table 2
env mutations identiﬁed in adapted viruses.
Virus Cells used for
selection
SUenv mutations No. clones
Mo-S82F NIH 3T3 F82S 3
F82S,E59K 1
F82S,T18A 1
SC-1 – 3
D40G,Y60C,S77G 1
Spl574 NIH 3T3 F82S 3
F82S,K104E 1
F82S,P3A 1
F82S,G115R,P120S,K129R,C131R 1
L48S 1
F82L 1
E114G,D135G 1
E114G 4
SC-1 - 1
F82S 5
F82S,A150T 1
E114G 1suggesting that this mutation may have been present in the
Spl574 virus stock.
We used site-speciﬁc mutagenesis to introduce E114G into
MoMLV either alone or together with S82F. E114G altered the
ability of MoMLV to infect M. dunni cells; this mutant virus
efﬁciently infected NIH 3T3 and M. dunni cells, indicating that
residues at this site inﬂuence host range (Table 1). Viruses
carrying both E114G and S82F show increased infectivity for
NIH 3T3 compared with Mo-S82F. The E114G mutation also
permitted MoMLV to infect E36 Chinese hamster cells, although
infection was inefﬁcient (Table 1).Pathogenicity of mutant viruses
Viruses carrying both mutations or only S82F were cytopathic
on M. dunni cells. Comparable virus titers for the double mutant
were obtained when measured by syncytia formation on M. dunni
cells (106.1/ml) or by the XC test (106.3/ml). The virus carrying
both E114G and S82F was also found to be cytopathic in NIH 3T3
and SC-1 cells, where syncytia of multinucleated cells were
observed 2–4 days after infection (Fig. 1). Titration of this virus
in NIH 3T3 using the XC test or by direct syncytium count gave
comparable numbers (104.9 vs. 104.5).
The mutant viruses were tested for cytopathicity and infectiv-
ity in rat and Lec8 Chinese hamster cell lines. These cells are
susceptible to E-MLVs but carry CAT-1 receptor variants that
differ in the receptor determining third extracellular loop (Eiden
et al., 1994; Takase-Yoden and Watanabe, 1999). Rat-2 cells are
efﬁciently infected by MoMLV and Mo-E114G, but were comple-
tely resistant to infection by viruses with S82F or with S82F and
E114G (Table 1). On most hamster cells, infectivity by E-MLVs is
restricted by glycosylation (Miller and Miller, 1992), but hamster
Lec8 cells, a derivative of Chinese hamster ovary cells, lack
GlcNAc-transferase I and show reduced levels of protein glycosy-
lation. Infection of Lec8 cells by MoMLV, Mo-E114G, and Mo-
S82F,E114G was efﬁcient, with XC test titers above 104.5/ml, but
no syncytia were observed. These results suggest infectivity and
cytopathicity are independently inﬂuenced by polymorphisms in
the virus binding sites of the CAT-1 receptor.
Retroviruses that induce disease in their hosts are often
cytopathic in cultured cells, such as HIV-1, avian leukosis viruses
and some pathogenic bovine and feline leukemia viruses (Cheng-
Mayer et al., 1988; Rohn et al., 1998; Weller and Temin, 1981).
Cytopathicity has been linked to the failure of these viruses to
establish effective superinfection immunity against further infec-
tion (Temin, 1988), is marked by the massive accumulation of
viral DNA (Weller and Temin, 1981), and may result, in part, from
apoptosis induced by endoplasmic reticulum stress responses
(Nanua and Yoshimura, 2004). Spl574 had not been tested for
pathogenicity in mice because of its restricted infectivity in cells
of laboratory mice. Because of the expanded host range and
cytopathicity of Mo-S82F,E114G, and because E116G had been
implicated in neurological disease caused by PVC-211 (Masuda
et al., 1996a; Masuda et al., 1993), we infected neonatal mice and
monitored the animals for signs of morbidity (Fig. 2). 50% of the
14 MoMLV infected mice were moribund with leukemia at 12
weeks and 100% had died by 20 weeks, and a similar morbidity
pattern was observed in mice inoculated with the mutant virus
with 50% of the 11 inoculated mice moribund by 17 weeks. All
mice developed lymphoma.
The syncytium-inducing TR1.3 and M813 mouse gammaretro-
viruses induce neurologic disease and T cell lymphoma, respec-
tively, that are characterized by the presence of multinucleated
cells (Park et al., 1994; Prassolov et al., 2001). Tissues from
leukemic mice inoculated with Mo-S82F,E114G were examined
Fig. 1. Syncytium formation in cells infected with MoMLV variants. 2–4 days after virus infection, cells were photographed by light microscopy using a Nikon TS100
microscope and digital camera DXM1200 with a 10 objective lens.
Fig. 2. Pathogenicity of MoMLV (open squares) and Mo-S82F,E116G (closed
triangles) in NFS/N mice inoculated intraperitoneally as neonates.
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were observed.
Two mice were sacriﬁced two months after inoculation with
the mutated virus. Suspensions of spleen and thymus were used
to infect cultures of SC-1 cells. E-MLV was detected by the XC test
in those cultures, and env genes were sequenced. Two types of env
genes were identiﬁed: revertants that resembled MoMLV, and env
genes marked by acquisition of adjacent serine codons at position
76, a change that has been associated with expanded MoMLV host
range (Jung and Kozak, 2003). The reversion of these mutations
in vivo could therefore account for the failure to detect multi-
nucleated cells in the tissues of inoculated mice, and the delay in
the disease latency period relative to MoMLV may result from the
time required for outgrowth of these mutated viruses.Discussion
Passage of cytopathic MoMLVs carrying the S82F env mutation
on restrictive NIH 3T3 or SC-1 cells produced genetically modiﬁedviruses. One mutation, E114G, was frequently present together
with S82F, and introduction of either or both of these two
mutations into MoMLV had phenotypic consequences. Viruses
with S82F efﬁciently infect and are cytopathic in M. dunni, but
show reduced infectivity on other mouse cells and are completely
restricted in rat cells. The E114G substitution permits infection of
hamster cells, and suppresses restriction due to S82F in mouse
cells, but not in rat cells. E114G, however, does not also suppress
S82F-induced syncytium formation; virus with both mutations is
cytopathic on all 3 mouse cells but not on hamster or rat cells. The
virus did not induce unusual pathology in mice, but virus
recovered from inoculated animals showed reversion at the
key sites.
These experiments were done in an attempt to identify
important functional residues in SU that may affect afﬁnity for
the different CAT-1 receptor variants. The observed phenotypic
differences may result from altered interactions between these
viruses and the 4 variant CAT-1 receptors found in SC-1 and NIH
3T3 (mCAT-1), M. dunni (dCAT-1), hamster, and rat cells. Relative
to mCAT-1, dCAT-1 has a glycine insertion in the NVKYGE
receptor determining region of the third extracellular loop and a
nearby I214V substitution, while the hamster and rat receptors
have additional substitutions as well as insertions of 6 and
3 residues, respectively (Eiden et al., 1994; Takase-Yoden and
Watanabe, 1999). Our previous studies have determined that
cytopathicity due to S82F is receptor inﬂuenced (Yan et al.,
2008), and the results presented here suggest that E114G has a
role in entry that is also receptor type speciﬁc. Previous studies on
the unusual ability of the PVC-211 FrMLV to infect hamster cells
and brain capillary endothelial cells attributed this altered host
range to this same substitution, E116G, together with E129K
(Masuda et al., 1996a; Masuda et al., 1996b).
The ﬁrst 236 residues of the E-MLV SUenv constitute the
receptor binding domain (RBD), and previous work identiﬁed
several residues within the RBD that are important for virus
binding, cell fusion and infection (Bae et al., 1997; MacKrell et al.,
1996). The 3 residues determined to be critical for virus entry by
mutagenesis (S84, D86, W102) were placed in a receptor binding
pocket at the top of the FrMLV RBD crystal structure (Davey et al.,
1999; Fass et al., 1997) (Fig. 3). Additional residues involved in
cell-virus fusion are near the N- and C-terminal ends of RBD and
are likely to be in close proximity at the base of the RBD structure
(Zavorotinskaya and Albritton, 1999). The mutated residue iden-
tiﬁed in the present study, E114 (E116 in FrMLV), is not part of the
receptor binding pocket (Fig. 3). However, this residue is exposed
to the surface and is well-positioned near the binding pocket at
Fig. 3. Surface representation of the FrMLV RBD. The 3 critical residues at the
binding pocket of this structure (PDB ID 1AOL) (Fass et al., 1997) are shown in red,
and E116 (E114 in MoMLV) is in blue.
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point of contact with the cell surface receptor. Replacement
mutations at this site could alter surface architecture and/or alter
receptor interactions. The 3 residues in the pocket may thus
provide the critical portion of a larger interface between SU and
receptor, and previous mutational studies may have either over-
looked residues like this one, that make small contributions to
receptor binding, or may have failed to evaluate the key receptor–
virus combinations or substitutions. Our results thus suggest the
existence of additional points of receptor–envelope contact
that can modulate this interaction for certain receptor–virus
combinations.
Previous studies have also concluded that while receptor
mediated entry and cytopathicity are both inﬂuenced by sub-
stitutions in the virus binding pocket and in the receptor virus
attachment site, these phenomena are not necessarily linked.
Thus, although virus entry and cytopathicity are both altered in
M. dunni cells which carry the dCAT-1 variant, it was shown that
ferret cells expressing dCAT-1 or mCAT-1 are equally infectible by
E-MLVs although only dCAT-1 transfectants are susceptible to
S82F-induced cytopathicity (Yan et al., 2008). A similar lack of
correlation between infectivity and cytopathicity was reported in
a mouse cell line that was unusually resistant to HTLV Env-
mediated syncytium formation, although it was highly suscepti-
ble to virus infection (Kim et al., 2003). Also, chloroquine treat-
ment blocks MoMLV entry, but not syncytium formation in a cell
line subject to MoMLV syncytium formation (Wilson et al., 1992).
One possible explanation for this disconnect may be the involve-
ment of additional host factors operating at entry, and there is
evidence for such a cofactor for other gammaretrovirus receptors
(Xu and Eiden, 2011). This could also explain why the restriction
of MoMLV by M. dunni is reproduced in human cells expressing
dCAT-1 (Eiden et al., 1993) but not in transfected ferret cells (Yan
et al., 2008). A second possible explanation is that host factors
may differentially inﬂuence post-entry processes. This is consis-
tent with reports of Env-determined post-entry restrictions forsome retroviruses (Oliveira et al., 2010), and would explain why
ferret dCAT-1 transfectants show restrictions in single-round
infectivity assays but not in assays that measure productive virus
infection or syncytia formation (Yan et al., 2008). Third, if virus/
receptor polymorphisms result in small changes in afﬁnity for the
receptor, this may be insufﬁcient to produce measurable changes
in entry levels using a single round infection assay, but sufﬁcient
to slow receptor downregulation. The failure to establish super-
infection immunity and the consequent accumulation of viral
DNA and viral protein are a hallmark of syncytium formation by
Spl574 (Jung et al., 2004) and other cytopathic retroviruses
(Cheng-Mayer et al., 1988; Rohn et al., 1998; Weller and Temin,
1981). Such a link to receptor binding kinetics was reported for
the cytopathic TR1.3 MLV which shows signiﬁcantly reduced
receptor binding avidity along with the inability to block super-
infection (Murphy et al., 2006). That the cytopathic response to
S82F represents a short-term delay in receptor downregulation is
suggested by the eventual outgrowth in infected cultures of
cells with normal morphology and growth properties despite
continued production of cytopathic viruses (CAK, unpublished
observation).
Among the sequenced infectious E-MLVs, E114/116 is found in
most of the FMR laboratory strains of E-MLVs (Friend, Moloney,
Rauscher), while G116 is found in naturally occurring, noncyto-
pathic E-MLVs like AKV and SL3-3. The E116G substitution has
been linked to the neuropathogenicity of some FrMLVs and their
ability to infect brain capillary endothelial cells and hamster cells
(Masuda et al., 1996a; Masuda et al., 1996b; Masuda et al., 1993).
The presence of E116G in the AKV-like E-MLVs is, however,
insufﬁcient to render these viruses infectious for hamster cells,
but it should be noted that these viruses differ signiﬁcantly in env
sequence from MoMLV with 82% identity, dropping to 72% in the
receptor determining VRA region of the RBD. This suggests that
the effect of substitutions at position 114/116 is dependent on
other residues that distinguish the FMR and AKV E-MLVs.Materials and methods
Viruses and cells
Spl574 was isolated from a M. spicilegus mouse neonatally
inoculated with MoMLV obtained from J. Hartley (NIAID, Bethesda,
MD) (Jung and Kozak, 2003). For infection assays, MoMLV was
derived from the pNCA clone of MoMLV (Colicelli and Goff, 1985)
following transfection into NIH 3T3 cells. The SUenv mutation S82F
was introduced into pNCA as described previously (Jung and Kozak,
2003). E114G was introduced by overlap PCR using forward primer
50–CCAGACAACTCATAAATCAAATGGAGGATTTTATGTTTGCCCCGG and
its reverse complement.
Virus titers were determined by the XC overlay test after
infecting cultures of NIH 3T3, SC-1 (Hartley and Rowe, 1975), M.
dunni (Hartley and Rowe, 1975), Rat2 cells (CRL-1764), and
Chinese hamster E36 cells (Gillin et al., 1972) or Lec8 cells (CRL-
1737). Cells were plated at 1–2105 cells/60 mm dish and
infected with 0.2 ml of appropriate dilutions of virus stocks in
the presence of polybrene (4 ug/ml; Aldrich, Milwaukee, WI).
Cultures were irradiated 4 days after virus infection and overlaid
with 106 XC cells/plate. Plates were ﬁxed and stained 3 days later
and examined for plaques of syncytia.
To screen for the formation of multinucleated syncytium in
virus infected cells, 2104 cells in six-well tissue culture plates
or 105 cells in 60 mm plates were infected with virus-containing
medium in the presence of 4 ug/ml polybrene. After 2–4 days, the
cells were examined by light microscopy using objective lenses of
J. Ferrarone et al. / Virology 433 (2012) 7–11 114x–20x and photographed using a Nikon TS100 microscope and
digital camera DXM1200.
Sequence analysis of virus with expanded host range
DNA was isolated from NIH 3T3 and SC-1 cells infected with
culture adapted Spl574 and Mo-S82F, and used as a template to
amplify env genes using forward primer 50–GGATACACGCCGCC-
CACGT and reverse primers 50–GCCCCAATAGGCACAGTAGA or
50CCGATTGACTGAGTCGCCCG. Products were subcloned into the
pCR2.1-TOPO vector and sequenced.
Pathogenesis
Pathogenicity of MoMLV and Mo-S82F,E116G was examined in
NFS/N mice inoculated intraperitoneally as neonates. Mice were
inoculated with 105.5 XC plaque forming units per animal and
monitored weekly for gross evidence of disease. Moribund mice
were sacriﬁced and subjected to histopathological analysis. Ani-
mals with grossly enlarged lymphoid organs were conﬁrmed to
have lymphoma by histologic examination. Virus was also iso-
lated from lymphoid tissues of 2 mice infected with mutant virus
and env genes were sequenced as described above. These studies
were performed in accordance with the guidelines of the Com-
mittee on the Care and Use of Laboratory Animals under an
NIAID-approved animal study protocol what was also approved
by the NIH Institutional Animal Care and Use Committee.Acknowledgments
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